High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

Omar Youssef(University of Helsinki), Raimo Pakkanen, Jaakko Kaprio(University of Helsinki), Max Tamlander(University of Helsinki), Anne Pitkäranta, Antti Hakanen, Jani T. Tikkanen(University of Oulu), George Okafo, Dirk S. Paul(AstraZeneca (United Kingdom)), Simonne Longerich, Elina Kilpeläinen(University of Helsinki), Tomi P. Mäkelä(University of Helsinki), Sanni Ruotsalainen(University of Helsinki), Anu Loukola(University of Helsinki), Jari A. Laukkanen(University of Eastern Finland), Samuli Ripatti(Broad Institute), Outi Tuovila, Nina Mars(Broad Institute), Bridget Riley-Gills, Raisa Serpi, Matthias Gossel, Howard J. Jacob(Medical College of Wisconsin), Terhi Kilpi(Finnish Institute for Health and Welfare), Taneli Raivio(University of Helsinki), Margaret G. Ehm(GlaxoSmithKline (United States)), Yossra H.S. Zidi-Mouaffak(University of Helsinki), Aarno Palotie(Broad Institute), Joseph Maranville(Finnish Institute for Health and Welfare), Chris O’Donnell, Mark McCarthy(GlaxoSmithKline (United States)), Clément Chatelain, Slavé Petrovski(AstraZeneca (United Kingdom)), Robert M. Plenge, Heiko Runz(Biogen (United States)), Robert Yang, Kirsi Auro, Veli-Matti Kosma(University of Eastern Finland), Tarja Laitinen, Marco Hautalahti(Business Finland), Sally John, Petri Virolainen, Katherine Klinger, Anders Mälarstig(Pfizer (United States)), Robert Graham(Janssen (Belgium)), Jukka Partanen, Markus Perola(University of Helsinki), Heli Salminen‐Mankonen, Karol Estrada(Erasmus MC), Mark Daly, Nathan Lawless
Laboratory Investigation
January 14, 2024
Cited by 5


Related Papers